Endexx Corporation develops hemp-derived, cannabidiol (CBD)-based products, each formulated to address key segments of the health and wellness market. Through its subsidiaries and strategic partnerships, the Company sells oils, extracts, topicals, and pet products, all with the shared purpose of supporting the therapeutic relief of pain and inflammation for humans and pets through its e-commerce site www.cbdunlimited.com, as well as other online and in-store retailers. In addition to its consumer products, the Company's Gorilla-Tek division offers an automated dispensing system providing a secure method of distributing hemp-based products. The Company also owns and operates a number of subsidiaries that offer technology and consulting solutions to the hemp and hemp-derived product industry, including Seed-to-Shelf compliance and inventory tracking and process management system for regulated products in a front of counter pharmacy support platform.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Annual Dividend Rate
Price/Cash Flow (TTM)